Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albireo Pharma Inc (NASDAQ:ALBO)

23.23
Delayed Data
As of 1:59pm ET
 +0.09 / +0.39%
Today’s Change
15.31
Today|||52-Week Range
29.20
+31.02%
Year-to-Date
No recent news for Albireo Pharma Inc.

Today’s Trading

Previous close23.14
Today’s open23.18
Day’s range23.03 - 23.60
Volume6,198
Average volume (3 months)30,973
Market cap$209.5M
Data as of 1:59pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)+4.42%
Earnings growth (this year)+47.08%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales1.93
Price/Book4.01

Competitors

 Today’s
change
Today’s
% change
ZYMEZymeworks Inc-0.04-0.49%
MNKDMannKind Corp-0.07-2.32%
CMRXChimerix Inc0.000.00%
MDGLMadrigal Pharmaceuti...-3.33-4.11%
Data as of 2:15pm ET, 12/14/2017

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$11.4M
Annual profit (last year)-$16.4M
Net profit margin-143.88%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President &
Chief Executive Officer
Ronald Cooper
Chief Operating Officer
Jan Peter Mattsson
Corporate headquarters
Boston, Massachusetts

Forecasts